Akebia Therapeutics Inc. (AKBA) climbed 5.6% or 0.35 to $6.6. It is near to 2.05 million shares traded, which is 149.87% compare to the average total volume 1.37 million. The market cap of AKBA is $673.99 million. The year to date change is 13.36%. The 52 week price range is from $5.2 to $15.82. Price of AKBA have changed 13.02% during last week. It have changed -26.73% over last month, -27.16% over last 3 months, -37.44% over last 6 months and -58.61% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AKBA is 7.47. It is 13.18% above current price. The 200-day Moving Averages for AKBA is 8.98. It is 36.06% above current price. The 52-week High is 15.82. It is 139.70% from the current price. The 52-week Low is 5.2. It is -21.21% from current price.
There are some statistics of AKBA. It is has market cap $673.99 million. The share outstanding is 102.12 million. The average volume is 1.37 million. The percent of top 15 Institution holding is 55.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AKBA is -59.04%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AKBA is -19.29%.